Inactive Instrument
CV Sciences Inc Stock OTC Bulletin Board
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-15 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 3.88M 3.37M 3.14M 2.89M 5.44M 369M 5.54M 37.08M 14.52M 184M 14.56M 14.23M 608M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.59M 4.86M 4.54M 4.17M 7.86M 533M 7.99M 53.52M 20.96M 266M 21.01M 20.55M 877M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.39% | -6.36% | +47.10% | +149.66% | 1,024B | ||
| -0.76% | -4.34% | +52.04% | +49.09% | 618B | ||
| -2.33% | -4.60% | +25.55% | +64.44% | 443B | ||
| +0.68% | -1.14% | +38.47% | +33.36% | 349B | ||
| -1.66% | -3.13% | +32.18% | +39.79% | 297B | ||
| -8.96% | -10.77% | +3.57% | +5.50% | 264B | ||
| -1.37% | -7.41% | -2.10% | -43.67% | 209B | ||
| -1.63% | +0.69% | +27.62% | +64.23% | 208B | ||
| +0.72% | +0.48% | +15.88% | +73.64% | 162B | ||
| Average | -1.54% | -3.14% | +26.70% | +48.45% | 397.08B | |
| Weighted average by Cap. | -0.98% | -3.91% | +34.56% | +70.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.65M 12.74M 11.7M 22.06M 1.5B 22.44M 150M 58.85M 746M 58.99M 57.68M 2.46B | 13.79M 11.98M 11.19M 10.27M 19.37M 1.31B 19.7M 132M 51.67M 655M 51.79M 50.65M 2.16B |
| Net income | -2.39M -2.08M -1.94M -1.78M -3.36M -228M -3.42M -22.9M -8.97M -114M -8.99M -8.79M -375M | -958K -833K -777K -714K -1.35M -91.31M -1.37M -9.17M -3.59M -45.54M -3.6M -3.52M -150M |
| Net Debt | 325K 282K 264K 242K 456K 30.98M 464K 3.11M 1.22M 15.45M 1.22M 1.19M 50.95M | 1.72M 1.49M 1.39M 1.28M 2.41M 164M 2.46M 16.44M 6.44M 81.66M 6.45M 6.31M 269M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions

















